Endoscopic stent placement has become accepted palliative therapy for
malignant biliary tract obstruction. Because stent occlusion remains a
significant late complication, prophylactic replacement has been sugg
ested, although the appropriate time interval remains unclear. Patient
s with malignant biliary strictures who received 10F or 11.5F stents w
ere analyzed with respect to clinical response, occlusion rates at 3 a
nd 6 months, and survival rates. Seventy stents were placed in 50 pati
ents. Pancreatic carcinoma was the most common underlying malignancy.
Overall, obstructive symptoms resolved in 94% of cases. Occlusion rate
s at 3 months (4.2%) and 6 months (10.8%) were not significantly diffe
rent. Median overall survival averaged 22 weeks. Results were also str
atified by underlying diagnosis, with the worst clinical response and
survival being seen in the group of patients with metastatic cancer. F
indings suggest that the time interval for stent replacement can be ex
tended safely from 3 to 6 months, resulting in decreased patient disco
mfort and cost and obviating any replacement in that significant perce
ntage of patients who expire before 6 months.